Drugs / LRG-002
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04321460 | Oct 2020 → Jan 2021 | diarrheal disease | Sandoz | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LRG-002 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04321460 ↗ |
| Modality | Other / unclassified | “Capsules containing live lyophilized probiotic bacteria of Lactobacillus genus” NCT04321460 ↗ |
| Route | Oral | “the product was to be taken orally 2 times per day for 14 days” NCT04321460 ↗ |